Shares of E*Trade (NASDAQ: ETFC) are up more than 8% on news that insiders and directors have acquired $1.9 million worth of stock in recent days. But investors should be cautious.
The buying was in all probability coordinated to send a message to investors -- and Wall Street is eating it up. But the reality is that $1.9 million is just not that much money in the context of the amount that the company top executives are paid.
The insider buying, in conjunction with the money E*Trade will spend on Super Bowl ads, looks like a pretty desperate and transparent effort by the company to convince investors and customers that the company is OK.
But think about it: if everything is so rosy, why isn't Ameritrade (NASDAQ: AMTD) jumping in with an offer to acquire the company, something it had previously contemplated doing at a much higher price?
E*Trade executives appear to be hoping that if they can convince people everything is peachy, it will be. But that's not a game you want to be playing.
Last updated: February 10, 2012: 11:58 AM
Hot Stocks
DailyFinance Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
Benzinga Headlines
- Don't Bank on Barclays
- GSV Capital Punished for Expanding Facebook Investment
- Chesapeake Gently Lets Go of Gas
- How to Profit off Addicts
- The Pepsi Challenge for 8,700 People is to Find a New Job
TheFlyOnTheWall.com Headlines
- Morgans Hotel management to meet with JMP Securities
- JPMorgan management to meet with Sterne Agee
- International Paper, Temple-Inland settle with DOJ over merger
- W.R. Grace management to meet with CL King
- Compuware management to meet with Jefferies
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
Savings Experiment: Snow Removal
The Money Man Behind Rick Santorum: Who Is Foster S. Friess?


Reader Comments (Page 1 of 1)
1-30-2008 @ 2:28PM
Barry said...
While what you are saying is true in terms of $1.9M being a small amount bought into the company, and clearly it is well timed with the announcement of the super-bowl ads - I have to seriously disagree with your logic about AMTD not buying e*trade.
Firstly, both Schwab and TD Ameritrade were contemplating a purchase of e*trade earlier this year - however they were so confident that customers would orgaincally leave e*trade and migrate to their platforms that they decided not to pick up this great company at a great price. Citadel - quite simply a smarter investing company - saw no problem buying a huge stake in e*trade.
Either way, I do consider this news about the execs. buying stock to be manipulating and transparent. But don't look down at the stock just because AMTD didn't capitalize on this opportunity - they can't even get their platform right.
Thanks,
Barry
http://www.buffettjr.com